These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1676448)

  • 21. S-adenosylmethionine treatment of depression: a controlled clinical trial.
    Bell KM; Plon L; Bunney WE; Potkin SG
    Am J Psychiatry; 1988 Sep; 145(9):1110-4. PubMed ID: 3046382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis of cobalamin neuropathy: deficiency of nervous system S-adenosylmethionine?
    Metz J
    Nutr Rev; 1993 Jan; 51(1):12-5. PubMed ID: 8446302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial.
    Kagan BL; Sultzer DL; Rosenlicht N; Gerner RH
    Am J Psychiatry; 1990 May; 147(5):591-5. PubMed ID: 2183633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antidepressive action of S-adenosylmethionine compared to nomifensine maleate].
    Scaggion G; Baldan L; Domanin S; Sivo M; Cenci I; Beggio R; Castorina G
    Minerva Psichiatr; 1982; 23(2):93-7. PubMed ID: 6761538
    [No Abstract]   [Full Text] [Related]  

  • 25. A new treatment for depression: S-adenosylmethionine. An international symposium. Trieste, Italy, June 18, 1987. Proceedings.
    Ala J Med Sci; 1988 Jul; 25(3):291-319. PubMed ID: 3177803
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence of brain methyltransferase inhibition and early brain involvement in HIV-positive patients.
    Keating JN; Trimble KC; Mulcahy F; Scott JM; Weir DG
    Lancet; 1991 Apr; 337(8747):935-9. PubMed ID: 1678030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open trial of S-adenosylmethionine for treatment of depression.
    Lipinski JF; Cohen BM; Frankenburg F; Tohen M; Waternaux C; Altesman R; Jones B; Harris P
    Am J Psychiatry; 1984 Mar; 141(3):448-50. PubMed ID: 6367496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of geriatric major depression from Alzheimer's disease with CSF tau protein phosphorylated at threonine 231.
    Buerger K; Zinkowski R; Teipel SJ; Arai H; DeBernardis J; Kerkman D; McCulloch C; Padberg F; Faltraco F; Goernitz A; Tapiola T; Rapoport SI; Pirttilä T; Möller HJ; Hampel H
    Am J Psychiatry; 2003 Feb; 160(2):376-9. PubMed ID: 12562590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central-nervous-system methyl-group metabolism in children with neurological complications of HIV infection.
    Surtees R; Hyland K; Smith I
    Lancet; 1990 Mar; 335(8690):619-21. PubMed ID: 1969014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S-adenosylmethionine in depression. A literature review and preliminary report.
    Janicak PG; Lipinski J; Davis JM; Comaty JE; Waternaux C; Cohen B; Altman E; Sharma RP
    Ala J Med Sci; 1988 Jul; 25(3):306-13. PubMed ID: 3052139
    [No Abstract]   [Full Text] [Related]  

  • 31. S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice.
    Fuso A; Nicolia V; Ricceri L; Cavallaro RA; Isopi E; Mangia F; Fiorenza MT; Scarpa S
    Neurobiol Aging; 2012 Jul; 33(7):1482.e1-16. PubMed ID: 22221883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Switch and S-adenosylmethionine.
    Carney MW; Chary TK; Bottiglieri T; Reynolds EH
    Ala J Med Sci; 1988 Jul; 25(3):316-9. PubMed ID: 3052141
    [No Abstract]   [Full Text] [Related]  

  • 33. An open-label pilot study of oral S-adenosylmethionine in major depression. An interim report.
    Rosenbaum JF; Fava M; Falk WE; Pollack MH; Cohen LS; Cohen BM; Zubenko GS
    Ala J Med Sci; 1988 Jul; 25(3):301-6. PubMed ID: 3052138
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of the one-carbon cycle in neuropsychiatric disease.
    Smythies JR
    Biol Psychiatry; 1984 May; 19(5):755-8. PubMed ID: 6329330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond.
    Dayon L; Guiraud SP; Corthésy J; Da Silva L; Migliavacca E; Tautvydaitė D; Oikonomidi A; Moullet B; Henry H; Métairon S; Marquis J; Descombes P; Collino S; Martin FJ; Montoliu I; Kussmann M; Wojcik J; Bowman GL; Popp J
    Alzheimers Res Ther; 2017 Jun; 9(1):43. PubMed ID: 28623948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood levels of S-adenosylmethionine in unmedicated schizophrenic and depressive patients.
    Maj M; Zizolfi S; Del Vecchio M
    Neuropsychobiology; 1981; 7(4):188-91. PubMed ID: 7266824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood S-adenosyl-L-methionine levels in psychiatric disorders.
    Cohen BM; Lipinski JF; Vuckovic A; Prosser E
    Am J Psychiatry; 1982 Feb; 139(2):229-31. PubMed ID: 7055296
    [No Abstract]   [Full Text] [Related]  

  • 38. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G; Galzenati M; Balbi A
    Adv Biochem Psychopharmacol; 1982; 32():151-6. PubMed ID: 7046362
    [No Abstract]   [Full Text] [Related]  

  • 39. CSF triiodothyronine (rT3) levels in patients with affective disorders.
    Linnoila M; Cowdry R; Lamberg BA; Makinen T; Rubinow D
    Biol Psychiatry; 1983 Dec; 18(12):1489-92. PubMed ID: 6661475
    [No Abstract]   [Full Text] [Related]  

  • 40. [S-Adenosyl-L-methionine. Latest results on its efficacy as an antidepressive agent].
    Ortiz P
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1988; 16(3):201-3. PubMed ID: 3218569
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.